XOMA Corp (XOMA) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

XOMA XOMA Corp

Watchlist

26.760
-0.300-1.11%

Close Feb 14 16:00 ET

25.200
-1.560-5.83%

Post 20:01 ET

315.31MMarket Cap-8.72P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
GlobeNewswireFeb 4 07:30 ET
Forecasting The Future: 5 Analyst Projections For XOMA Royalty
BenzingaFeb 3 16:00 ET
H.C. Wainwright Maintains XOMA Corp(XOMA.US) With Buy Rating, Cuts Target Price to $104
Moomoo NewsFeb 3 06:31 ET · Ratings
XOMA Corp(XOMA.US) 10% Shareholder Sells US$16.98 Million in Common Stock
Moomoo NewsJan 28 17:26 ET
XOMA Corp - 8.375% DP PFD B Declares $0.5234 Dividend
Seeking AlphaDec 19, 2024 08:32 ET
Press Release: XOMA Royalty Declares Quarterly Preferred Stock Dividends
Dow JonesDec 19, 2024 07:30 ET

Comments

Jaguar8

Dec 19, 2024 06:33

NEWS

$XOMA Corp (XOMA.US)$
XOMA Royalty Declares Quarterly Preferred Stock Dividends
Thursday, 19th December at 7:30 am
EMERYVILLE, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA's Series A and Series B Cumulative Preferred Stock:
Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (NASDAQ: XOMAP) shall receive a cash dividend equal to $0.53906 p...

Jaguar8

Oct 22, 2024 07:05

NEWS

$XOMA Corp (XOMA.US)$
XOMA Royalty Acquires 50% of Twist Bioscience's Royalty, Milestone Economics for $15M

Stock_Drift

Sep 23, 2024 04:38

0.53906 per share.

$XOMA Corp (XOMA.US)$

Trytosaveabit

Jun 12, 2024 06:34

Update

$XOMA Corp (XOMA.US)$ $Day One Biopharmaceuticals (DAWN.US)$ XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of Its Priority Review Voucher

Meltyy

Mar 20, 2024 10:18

Biotech Stock News 3/20

$Annovis Bio (ANVS.US)$ 22% Ph2/3 data reporting update
$Taysha Gene Therapies (TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals (TFFP.US)$ 14% Clinical programs update
$Jaguar Health (JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin (SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems (DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences (SLS.US)$ 0% Closes $20M offering & private placement
$Immunic (IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics (NRIX.US)$ 0...

XOMA XOMA Corp

Trade Overview

Capital Trend

News

Comments

Trending Stocks